Abstract
Induced fit docking approach was utilized to decipher the binding mode of the recently reported dibenz[b,f]1,5- oxazocine derivative having activity towards κ -Opioid receptor. The result of docking to newly resolved crystallographic structure of κ -Opioid receptor established the important interactions as two hydrogen bonds, a π-π interaction, and two hydrophobic interactions. Based on the study it is inferred that protonated nitrogen is not always essential for binding of non-peptidic nitrogen containing opioids to κ -Opioid receptor. Also, docking was performed using well-known kappa agonist pentazocine to prove different binding requirements of the dibenzo compound. A pharmacophoric model has been developed based on the previously known nitrogen containing κ -Opioid receptor agonists and the new dibenzo compound to determine the minimal 3D features, required for κ -Opioid agonist activity. To our knowledge, this is the first report of a binding mode analysis study for non-protonated nitrogen containing κ-Opioid receptor agonist.
Keywords: Agonist, Docking, Kappa opioid receptor, Non-peptidic, Opioids, Protonated nitrogen.
Letters in Drug Design & Discovery
Title:Positively Charged Nitrogen is Not Indispensable Requirement for Binding of Nitrogenous κ-Opioid Agonists: Insights from Docking Studies
Volume: 11 Issue: 6
Author(s): Indrani Bera and Nanda Ghoshal
Affiliation:
Keywords: Agonist, Docking, Kappa opioid receptor, Non-peptidic, Opioids, Protonated nitrogen.
Abstract: Induced fit docking approach was utilized to decipher the binding mode of the recently reported dibenz[b,f]1,5- oxazocine derivative having activity towards κ -Opioid receptor. The result of docking to newly resolved crystallographic structure of κ -Opioid receptor established the important interactions as two hydrogen bonds, a π-π interaction, and two hydrophobic interactions. Based on the study it is inferred that protonated nitrogen is not always essential for binding of non-peptidic nitrogen containing opioids to κ -Opioid receptor. Also, docking was performed using well-known kappa agonist pentazocine to prove different binding requirements of the dibenzo compound. A pharmacophoric model has been developed based on the previously known nitrogen containing κ -Opioid receptor agonists and the new dibenzo compound to determine the minimal 3D features, required for κ -Opioid agonist activity. To our knowledge, this is the first report of a binding mode analysis study for non-protonated nitrogen containing κ-Opioid receptor agonist.
Export Options
About this article
Cite this article as:
Bera Indrani and Ghoshal Nanda, Positively Charged Nitrogen is Not Indispensable Requirement for Binding of Nitrogenous κ-Opioid Agonists: Insights from Docking Studies, Letters in Drug Design & Discovery 2014; 11(6) . https://dx.doi.org/10.2174/1570180811666140220004853
DOI https://dx.doi.org/10.2174/1570180811666140220004853 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
The Efficacy of Psychological Therapies for Specific Phobias in Adults and Some Unanswered Questions
Current Psychiatry Reviews HspB5/αB-Crystallin: Properties and Current Progress in Neuropathy
Current Neurovascular Research Drug Disposition in Pathophysiological Conditions
Current Drug Metabolism The Use of Microarrays to Study Childhood Developmental Brain Disorders
Current Genomics How Would Composite Traditional Chinese Medicine Protect the Brain – An Example of the Composite Formula “Pien Tze Huang”
Current Medicinal Chemistry Redox Regulation and the Autistic Spectrum: Role of Tryptophan Catabolites, Immuno-inflammation, Autoimmunity and the Amygdala
Current Neuropharmacology The Development and Mechanism of Crude Oil Pour Point Depressant: A Mini-Review
Recent Innovations in Chemical Engineering The Emerging Role of microRNA in Stroke
Current Topics in Medicinal Chemistry Fragile X Syndrome and Alzheimers Disease: Another Story About APP and β -Amyloid
Current Alzheimer Research γ-Secretase as a Therapeutic Target for Treatment of Alzheimers Disease
Current Pharmaceutical Design Functional Selectivity in GPCR Heterocomplexes
Mini-Reviews in Medicinal Chemistry Subject Index to Volume 4
Current Cancer Drug Targets Ophthalmological and Otological Manifestations in the Antiphospholipid Syndrome
Current Rheumatology Reviews Design, Synthesis and PASS Assisted Evaluation of Novel 2-Substituted Benzimidazole Derivatives as Potent Anthelimintics
Medicinal Chemistry Dipyridamole: A Drug with Unrecognized Antioxidant Activity
Current Topics in Medicinal Chemistry Something Old, Something New and Something Used in Alzheimer's; the Idea of Pore, Ethanol and the Use of Oocytes to Understand the Disease
Current Chemical Biology Anti-Inflammatory Effects of Antidepressants: Possibilities for Preventives Against Alzheimers Disease
Central Nervous System Agents in Medicinal Chemistry Significance and Mechanisms of P-glycoprotein in Central Nervous System Diseases
Current Drug Targets Screening of Early and Late Onset Alzheimer’s Disease Genetic Risk Factors in a Cohort of Dementia Patients from Liguria, Italy
Current Alzheimer Research A Review on Medical Image Registration as an Optimization Problem
Current Medical Imaging